secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marpai, Inc. (MRAI)
CIK:        0001844392
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0000950170-24-012762
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marpai secures $1.7M revenue-based financing; amends AXA purchase deal to potentially reduce $3M obligation
--------------------------------------------------------------------------------

- Entered Libertas revenue-based financing: sold $2.193M future receipts for $1.7M; weekly payments over 9 months.
- AXA amendment reduces 2024 payment to $473,688 and defers further payments to 2025.
- Potential $3M reduction in AXA purchase price if CEO invests $3M equity, Nasdaq listing maintained, and payments made.
- CEO Damien Lamendola guarantees Libertas funding; also commits to $3M equity investment in 2024.
- Company expects to use Libertas proceeds for short-term working capital needs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844392/000095017024012762/0000950170-24-012762-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844392/000095017024012762/mrai-20240205.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-012762

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer